Article Details

GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK

Retrieved on: 2021-03-15 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK. View article details on hiswai:

Excerpt

... Achilles, Adaptimmune, Autolus, Freeline, TCR2, Rentschler Biopharma, and GSK - along with CDMOs and therapy developers of different sizes.

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up